Immunomodulation of human B cells following treatment with intravenous immunoglobulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-11-01
著者
-
Racine Claudia
Hema-quebec Ingenierie Cellulaire Recherche Et Developpement
-
Cote Serge
Hema-quebec Ingenierie Cellulaire Recherche Et Developpement
-
DUSSAULT Nathalie
Hema-Quebec, Ingenierie cellulaire, Recherche et developpement
-
DUCAS Eric
Hema-Quebec, Ingenierie cellulaire, Recherche et developpement
-
JACQUES Annie
Hema-Quebec, Ingenierie cellulaire, Recherche et developpement
-
PARE Isabelle
Hema-Quebec, Ingenierie cellulaire, Recherche et developpement
-
NERON Sonia
Hema-Quebec, Ingenierie cellulaire, Recherche et developpement
-
Ducas Eric
Hema-quebec Ingenierie Cellulaire Recherche Et Developpement
-
Neron Sonia
Hema-quebec Ingenierie Cellulaire Recherche Et Developpement
-
Jacques Annie
Hema-quebec Ingenierie Cellulaire Recherche Et Developpement
-
Pare Isabelle
Hema-quebec Ingenierie Cellulaire Recherche Et Developpement
-
Dussault Nathalie
Hema-quebec Ingenierie Cellulaire Recherche Et Developpement
関連論文
- Immunomodulation of human B cells following treatment with intravenous immunoglobulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2
- B cell proliferation following CD40 stimulation results in the expression and activation of Src protein tyrosine kinase